DAFNA Capital Management »

Verastem shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Verastem (VSTM) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Verastem

Tip: Access up to 7 years of quarterly data

All positions including Verastem held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verastem by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $382k 128k 2.99

More positions owned by DAFNA Capital Management

Spdr S&p Biotech Etf Etf (XBI)
Stereotaxis Com New (STXS)
Revolution Medicines (RVMD)
Cytokinetics Com New (CYTK)
Merus N V (MRUS)
AtriCure (ATRC)
Ideaya Biosciences (IDYA)
Ishares Nasdaq Biotech Indx Etf (IBB)
Ascendis Pharma A/s Sponsored Adr (ASND)
Axogen (AXGN)
Blueprint Medicines (BPMC)
Xenon Pharmaceuticals (XENE)
Day One Biopharmaceuticals I (DAWN)
Syndax Pharmaceuticals (SNDX)
Biohaven (BHVN)

View all positions for DAFNA Capital Management

Top funds holding Verastem

Nantahala Capital Management
OrbiMed Advisors
BlackRock
Alyeska Investment Group
BVF
Soleus Capital Management
BlackRock
Vanguard Group
Stonepine Capital Management
Geode Capital Management
Affinity Asset Advisors
State Street Corporation
Northern Trust
Tang Capital Management
Kennedy Capital Management

View all funds holding Verastem